What's in Instituto Bioclon S.A. de C.V.'s pipeline?

Instituto Bioclon S.A. de C.V. has 5 drugs in our index: 4 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Instituto Bioclon S.A. de C.V.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-bioclon-s-a-de-c-v.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Instituto Bioclon S.A. de C.V. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto Bioclon S.A. de C.V. pipeline: 4 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Anascorp	Anascorp	marketed			Other
Antivipmyn ®	Antivipmyn ®	marketed	Antivenom		Toxicology / Emergency Medicine
CroFab	CroFab	marketed	Antivenom (polyclonal antibody fragments)	Crotalid venom toxins (phospholipase A2, serine proteases, metalloproteinases)	Toxicology / Emergency Medicine
Anavip	Anavip	marketed			Other
Analatro	Analatro	phase 3			Other

Therapeutic area mix

Other · 3
Toxicology / Emergency Medicine · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Instituto Bioclon S.A. de C.V.:

Cite this brief

Drug Landscape (2026). Instituto Bioclon S.A. de C.V. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-bioclon-s-a-de-c-v. Accessed 2026-05-17.